(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDPOINT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

MEDPOINT

ST13

US500000088507409

Class

41, 42

Filing

88507409

Registration

6278614

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

07/02/2026

Classification

Registered

Trademark type

Word

Nice classes

41, 42

Filing date

07/10/2019

Registration date

02/23/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/23/2021

Last transaction

07/02/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/29/2011

First use in commerce

08/29/2011

Drawing code

4

Owner type

03

Owner location

Evanston, IL, US

Examiner

CASE, LEIGH CAROLINE

Law office

M30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Medpoint Communications, Inc.

Representatives

John L. Ambrogi LATIMER LEVAY FYOCK LLC

Technical classification

Nice Classes

Class 41Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

Training and support serviceslive digital training eventsweb site-based training modulesweb site-based training management center featuring instruction in the field of digital media support for clinical research; and training clinical research raters in the use of digital and web site-based systems

Class 42

Providing digital technology servicesSoftware as a Service services featuring a software platform for providing users access to documentstrainingmessagesalertsformsrelated materials in the field of medical and scientific research information and clinical trialscomputer services that provide web facilitiesa web-based system in the nature of online non-downloadable software and online portal in the field of medical and scientific research information and clinical trials that provides users access to documentstrainingmessagesalertsformsrelated materials; hosting secureaudit-ready compliant online web facilities for others for organizing and conducting online meetingsgatheringsinteractive discussions for the biopharma industryproviding a website featuring technology that enables clinical research associates to monitor investigative sites that are conducting clinical trials by means of live virtual meetings; providing an online non-downloadable live virtual meeting software platform to support remotedigital patient visits to investigator sites in the course of clinical trials for medicines and medical products by providing a website with technology that allows health care professional speakers to hold digital online meetings for virtual events over the internetthat allows users to hold virtual speaking events and advisory and pharmaceutical webcaststhat allows health care professionals to conduct virtual and online digital advisory and consulting meetingsthat allows uses to conduct virtual and online digital pharmaceutical and biotech training eventsthat allows uses to conduct and online digital speaking and virtual peer-to-peer programs; providing online non-downloadable computer software for document management processes for product marketingcommercializationmedical affairs and clinical research for medical productpharmaceutical and biotechnology companiesfor clinical trial document and records exchange and access which includes providing a hosted website portal in the nature of an online computer database featuring online information in the field of healthcare for use by healthcare professionals engaged in commercialization of medical products; providing online non-downloadable software for providing access to a portal that provides patients with information regarding clinical trials and allows them to stay connected and in control of their role as participants in clinical trials; providing support servicescomputer programmingcustomizing computer softwaresystem analysis and design for document management processes for product marketingcommercializationmedical affairs and clinical researchfor medical productpharmaceutical and biotechnology companies

Publications

History of USPTO decisions and trademark events.

33 publications found

E815

TEAS SECTION 8 & 15 RECEIVED

07/02/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/23/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

02/23/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/19/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/18/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/08/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/07/2021

EX1G

SOU EXTENSION 1 GRANTED

01/07/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/04/2021

IUAF

USE AMENDMENT FILED

12/15/2020

EXT1

SOU EXTENSION 1 FILED

12/15/2020

EEXT

SOU TEAS EXTENSION RECEIVED

12/15/2020

EISU

TEAS STATEMENT OF USE RECEIVED

12/15/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/16/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/21/2020

PUBO

PUBLISHED FOR OPPOSITION

04/21/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/01/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/13/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

03/10/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/10/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

03/10/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/10/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/20/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/20/2020

ALIE

ASSIGNED TO LIE

02/20/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/14/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/14/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/26/2019

GNRT

NON-FINAL ACTION E-MAILED

09/26/2019

CNRT

NON-FINAL ACTION WRITTEN

09/26/2019

DOCK

ASSIGNED TO EXAMINER

09/26/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/17/2019

NWAP

NEW APPLICATION ENTERED

07/13/2019

Continuous trademark protection

Get notified about every new filing that threatens MEDPOINT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.